ArticleNew Court Proceedings - September 2021New Court Proceedings.CanadaLitigation, Mediation & ArbitrationSmart & Biggar
ArticleUse Of Extensions In Mascara Advertising MisleadingIn a recent decision, the National Advertising Division took a stance against using lash inserts in mascara advertising making specific performance claims. CanadaMedia, Telecoms, IT, EntertainmentSmart & Biggar
ArticleDrip, Drip, Stop. Competition Bureau Putting An End To Misleading Pricing ClaimsThe Competition Bureau has made it clear that an enforcement priority is the practice of "drip pricing"; that is the advertisement of a price that is unattainable...CanadaAntitrust/Competition LawSmart & Biggar
Article2021 PMPRB Annual ReportOn November 21, 2022, the Minister of Health tabled the 2021 Annual Report of the Patented Medicine Prices Review Board.CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleAppeal Of Summary Dismissal Under PMNOC Regulations: Dismissal Order StayedWe previously reported that the Federal Court dismissed a Patented Medicines (Notice of Compliance) (PMNOC) Regulations application relating to Apotex's generic aripiprazole product...CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleBill C-30 Receives Royal AssentAs previously reported here, Bill C-30 was passed by the Senate on May 11, 2017. Bill C-30 is the bill that will implement the Canada-European Union Comprehensive Economic and Trade Agreement (CETA). CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleCADTH Common Drug Review To Accept Submissions Up To Six Months Prior To Market ApprovalThe Canadian Agency for Drugs and Technologies in Health (CADTH) announced on March 8, 2018 that, effective April 2, 2018, its Common Drug Review (CDR) ...CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleGuidance UpdatesHealth Canada released a revised Guidance Document: Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs on June 28, 2019CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleHealth Canada Implements Mandatory Use Of The Electronic Common Technical Document FormatAs previously reported, Health Canada announced January 1, 2018 as the proposed date for mandatory filing of specified regulatory activity.CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleHealth Canada Launches E-Learning Tool For Understanding Premarket Regulatory Requirements For Medical DevicesOn March 19, 2019, Health Canada published a Notice, announcing the launch of its e-Learning tool: Understanding How Medical Devices are Regulated in Canada – Premarket Regulation.CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleNew PMPRB Report Examines Most Promising Medicines Currently In Clinical Trials WorldwideOn May 30, 2019, the PMPRB published the 2018 edition of the Meds Pipeline Monitor, a horizon scanning report which provides a snapshot of the new drug landscape CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleOntario Bill 160 Requiring Disclosure Of Financial Relationships Between Pharmaceutical Companies And Health Care Professionals Receives Royal AssentThe Health Sector Payment Transparency Act, 2017 will come into force on a day to be named by proclamation of the Lieutenant Governor.CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticlePMPRB Extends Deadline For Consultation On Draft Guidelines To January 31, 2020On November 21, 2019, the Patented Medicine Prices Review Board (PMPRB) released draft Guidelines operationalizing the recent amendments to the Patented Medicines Regulations for consultation CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticlePMPRB Publishes 2017 Meds Entry WatchOn February 19, 2019, the Patented Medicine Prices Review Board (PMPRB) announced the publication of the 2017 edition of Meds Entry Watch. CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticlePMPRB Steering Committee On Modernization Of Price Review Process Guidelines Releases Final ReportOn July 2, 2019, the PMPRB Steering Committee on the Modernization of Price Review Process Guidelines released its final report summarizing CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleQuebec Initiating A Shift To Use Of Biosimilar DrugsAs previously reported, British Columbia, Alberta, and New Brunswick have all launched biosimilar initiatives which require that patients switch from certain reference biologics to biosimilars for certain indications.CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleStakeholder Consultation On Naming Of Biologic Drugs, Including BiosimilarsOn January 18, 2018, Health Canada and the Institute for Safe Medication Practices Canada (ISMP Canada) opened its consultation on different approaches to the naming of biologic drugs...CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleUnder Reserve: Appeal From Judicial Review Quashing PMPRB Decision On Jurisdiction Over DIFFERINOn January 17, 2019, the Federal Court of Appeal heard the Attorney General of Canada's appeal from a judicial review that quashed a Board decision that it has jurisdiction ...CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
ArticleUpdates To The IMC Code Of Ethical PracticesInnovative Medicines Canada (IMC) has announced changes to its Code of Ethical Practices for the first time since the last significant update in 2014.CanadaFood, Drugs, Healthcare, Life SciencesSmart & Biggar
